Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
The gut microbiota has been extensively studied in all health science fields because its imbalance is linked to many disorders, such as inflammation and oxidative stress, thereby contributing to cardiovascular disease, obesity, diabetes and chronic kidney disease (CKD) complications. Novel therapeut...
| Publicado en: | European Journal of Nutrition Vol. 55; no. 5; pp. 1813 - 1822 |
|---|---|
| Autores principales: | , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Springer Nature
Aug2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116870703&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 116870703 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14366207 CR0 jtl: European Journal of Nutrition issn: 14366207 maglogo: N pubinfo: dt: Aug2016 vid: 55 iid: 5 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 116870703 116870703 116870703 10.1007/s00394-015-1138-0 116870703 ppf: 1813 ppct: 9 formats: fmt: @attributes: type: P tig: atl: Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients? aug: au: Moraes, Cristiane Borges, Natália Mafra, Denise affil: Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói Brazil sug: subj: Microbiota Stomach Microbiology Prebiotics Therapeutic Use Glucans Therapeutic Use Renal Insufficiency, Chronic Therapy Glucans Physiology Renal Insufficiency, Chronic Metabolism Nitrogen Urine Fermentation Dietary Fiber Administration and Dosage Fatty Acids Metabolism Glucans Metabolism ab: The gut microbiota has been extensively studied in all health science fields because its imbalance is linked to many disorders, such as inflammation and oxidative stress, thereby contributing to cardiovascular disease, obesity, diabetes and chronic kidney disease (CKD) complications. Novel therapeutic strategies that aim to reduce the complications caused by this imbalance have increased in recent years. Studies have shown that prebiotic supplementation can beneficially modulate the gut microbiota in CKD patients. Prebiotics consist of non-digestible dietary soluble fiber, which acts as a substrate for the gut microbiota. Resistant starch (RS) is a type of dietary fiber that can reach the large bowel and act as a substrate for microbial fermentation; for these reasons, it has been considered to be a prebiotic. Few studies have analyzed the effects of RS on the gut microbiota in CKD patients. This review discusses recent information about RS and the potential role of the gut microbiota, with a particular emphasis on CKD patients. pubtype: Academic Journal doctype: review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|